The recognition and treatment of growth disorders A 50-year retrospective

Annals of Human Biology

Volumn 36, Issue 5, 2009, Pages 496-510

  Zemel, Babette ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Children; Cystic fibrosis; Growth; Sickle cell disease

Indexed keywords

ADULT; BIOLOGICAL ANALYSIS; BLOOD SYSTEM DISORDER; BODY SIZE; CHILD HEALTH; DISEASE TREATMENT; HORMONE; LIFE EXPECTANCY; MALNUTRITION; MATURATION; SURVIVAL;

CYSTIC FIBROSIS; FEMALE; GROWTH DISORDER; HUMAN; MALE; RETROSPECTIVE STUDY; REVIEW; SEXUAL DEVELOPMENT; SICKLE CELL ANEMIA; TIME;

ANEMIA, SICKLE CELL; CYSTIC FIBROSIS; FEMALE; GROWTH DISORDERS; HUMANS; MALE; RETROSPECTIVE STUDIES; SEX CHARACTERISTICS; TIME FACTORS;

EID: 70449633186     PISSN: 03014460     EISSN: 14645033     Source Type: Journal    
DOI: 10.1080/03014460902980303     Document Type: Review

References (105)

1. Adair LS. 2007. Size at birth and growth trajectories to young adulthood. Am J Hum Biol 19:327-337.
2. Adams RJ. 2000. Lessons from the Stroke Prevention Trial in Sickle Cell Anemia (STOP) study. J Child Neurol 15:344-349.
3. Alberman E, Filakti H, Williams S, Evans SJ, Emanuel I. 1991. Early influences on the secular change in adult height between the parents and children of the 1958 birth cohort. Ann Hum Biol 18:127-136.
4. Ashley-Koch A, Yang Q, Olney RS. 2000. Sickle hemoglobin (HbS) allele and sickle cell disease: A HuGE review. Am J Epidemiol 151:839-845.
5. Bachrach LK. 2001. Acquisition of optimal bone mass in childhood and adolescence. Trends Endocrinol Metab 12:22-28.
6. Barden EM, Kawchak DA, Ohene-Frempong K, Stallings VA, Zemel BS. 2002. Body composition in children with sickle cell disease. Am J Clin Nutr 76:218-225.
7. Barden EM, Zemel BS, Kawchak DA, Goran MI, Ohene-Frempong K, Stallings VA. 2000. Total and resting energy expenditure in children with sickle cell disease. J Pediatr 136:73-79.
8. Bell RC, Lanou AJ, Frongillo EA, Jr, Levitsky DA, Campbell TC. 1994. Accuracy and reliability of total body electrical conductivity (TOBEC) for determining body composition of rats in experimental studies. Physiol Behav 56:767-773.
9. Borel MJ, Buchowski MS, Turner EA, Goldstein RE, Flakoll PJ. 1998a. Protein turnover and energy expenditure increase during exogenous nutrient availability in sickle cell disease. Am J Clin Nutr 68:607-614.
10. Borel MJ, Buchowski MS, Turner EA, Peeler BB, Goldstein RE, Flakoll PJ. 1998b. Alterations in basal nutrient metabolism increase resting energy expenditure in sickle cell disease. Am J Physiol 274:E357-E564.
11. Brawley OW, Cornelius LJ, Edwards LR, Gamble VN, Green BL, Inturrisi C, James AH, Laraque D, Mendez M, Montoya CJ, Pollock BH, Robinson L, Scholnik AP, Schori M. 2008. National Institutes of Health Consensus Development Conference statement: Hydroxyurea treatment for sickle cell disease. Ann Intern Med 148: 932-938.
12. Brooke-Wavell K, Jones PR, Norgan NG, Hardman AE. 1995. Evaluation of near infra-red interactance for assessment of subcutaneous and total body fat. Eur J Clin Nutr 49:57-65.
13. Buison A, Kawchak D, Schall J, Ohene-Frempong K, Stallings V, Zemel B. 2004. Low vitamin D status in children with sickle cell disease. J Pediatr 145:624-629.
14. Buison AM, Ittenbach RF, Stallings VA, Zemel BS. 2006. Methodological agreement between two-compartment body-composition methods in children. Am J Hum Biol 18:470-480.
15. Cameron N, Kgamphe JS, Leschner KF, Farrant PJ. 1992. Urban-rural differences in the growth of South African black children. Ann Hum Biol 19:23-33.
16. Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, McMahon RP, Bonds DR. 1995. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med 332:1317-1322.
17. Cole TJ, Green PJ. 1992. Smoothing reference centile curves: The LMS method and penalized likelihood. Stat Med 11:1305-1319.
18. Cole TJ, Flegal KM, Nicholls D, Jackson AA. 2007. Body mass index cut-offs to define thinness in children and adolescents: International survey. BMJ 335:194.
19. Cole TJ, Freeman JV, Preece MA. 1995. Body mass index reference curves for the UK, 1990. Arch Dis Child 73:25-29.
20. Cronk C, Stallings V, Spender Q, Widdoes D. 1989. Measurement of short term linear growth with a new knee height measuring device. Am J Hum Biol 1:421-428.
21. Cystic Fibrosis Foundation. 2006. Patient Registry 2006 Annual Report. Bethesda, MD.
22. Cystic Fibrosis Foundation. 2008a. About CF: http://www.cff.org/AboutCF/.
23. Cystic Fibrosis Foundation. 2008b. Research Milestones: http://www.cff.org/research/ResearchMilestones/.
24. Daughaday WH. 2006. Endocrinology-the way we were: A personal history of somatomedin. Growth Horm IGF Res 16 (Suppl. A) A:S3-S5.
25. Davies JC, Alton EW, Bush A. 2007. Cystic fibrosis. BMJ 335:1255-1259.
26. de Bruin NC, van Velthoven KA, Stijnen T, Juttmann RE, Degenhart HJ, Visser HK. 1995. Body fat and fat-free mass in infants: New and classic anthropometric indexes and prediction equations compared with total-body electrical conductivity. Am J Clin Nutr 61:1195-1205.
27. de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J. 2007. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ 85:660-667.
28. Denham M, Schell LM, Gallo M, Stark A. 2001. Neonatal size of low socio-economic status Black and White term births in Albany County, NYS. Ann Hum Biol 28:172-183.
29. Eveleth P, Tanner JM. 1991. Worldwide variation in human growth. Cambridge: Cambridge University Press.
30. Fields DA, Higgins PB, Hunter GR. 2004a. Assessment of body composition by air-displacement plethysmography: Influence of body temperature and moisture. Dyn Med 3:3.
31. Fields DA, Hull HR, Cheline AJ, Yao M, Higgins PB. 2004b. Child-specific thoracic gas volume prediction equations for air-displacement plethysmography. Obes Res 12:1797-1804.
32. Friedman KJ, Leigh MW, Czarnecki P, Feldman GL. 1998. Cystic fibrosis transmembrane-conductance regulator mutations among African Americans. Am J Hum Genet 62:195-196.
33. Fuller NJ, Fewtrell MS, Dewit O, Elia M, Wells JC. 2002. Segmental bioelectrical impedance analysis in children aged 8-12 y: 2. The assessment of regional body composition and muscle mass. Int J Obes Relat Metab Disord 26:692-700. (Pubitemid 34499291)
34. Fung EB, Barden EM, Kawchak DA, Zemel BS, Ohene-Frempong K, Stallings VA. 2001. Effect of hydroxyurea therapy on resting energy expenditure in children with sickle cell disease. J Pediatr Hematol Oncol 23:604-608. (Pubitemid 34073867)
35. Gaston MH, Verter JI, Woods G, Pegelow C, Kelleher J, Presbury G, Zarkowsky H, Vichinsky E, Iyer R, Lobel JS, et al. 1986. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl JMed 314:1593-1599.
36. Gordon CM, Baim S, Bianchi ML, Bishop NJ, Hans DB, Kalkwarf H, Langman C, Leonard MB, Plotkin H, Rauch F, Zemel BS. 2008. Special Report on the 2007 Pediatric Position Development Conference of the International Society for Clinical Densitometry, Southern Medical Journal.
37. Guagnano MT, Ballone E, Merlitti D, Murri R, Pace-Palitti V, Pilotti R, Sensi S. 1997. Association between anthropometric and ultrasound measurements of fatness with ambulatory blood pressure monitoring in obese women. Int J Obes Relat Metab Disord 21:632-636.
38. Hermanussen M. 1988. Knemometry, a new tool for the investigation of growth. A review. Eur J Pediatr 147: 350-355.
39. Himes JH, Roche AF, Thissen D, Moore WM. 1985. Parent-specific adjustments for evaluation of recumbent length and stature of children. Pediatrics 75:304-313.
40. Hunt JA, Ingram VM. 1958. Abnormal human haemoglobins. II. The chymotryptic digestion of the trypsinresistant core of haemoglobins A and S. Biochim Biophys Acta 28:546-549.
41. Hunt JA, Ingram VM. 1960. Abnormal human haemoglobins. IV. The chemical difference between normal human haemoglobin and haemoglobin C. Biochim Biophys Acta 42:409-421.
42. Hunt JA, Ingram VM. 1961. Abnormal human haemoglobins. VI. The chemical difference between haemoglobins A and E. Biochim Biophys Acta 49:520-536.
43. Ittenbach RF, Buison AM, Stallings VA, Zemel BS. 2006. Statistical validation of air-displacement plethysmography for body composition assessment in children. Ann Hum Biol 33:187-201.
44. Jones G, Boon P. 2008. Which bone mass measures discriminate adolescents who have fractured from those who have not? Osteoporos Int 19:251-255.
45. Kammesheidt A, Kharrazi M, Graham S, Young S, Pearl M, Dunlop C, Keiles S. 2006. Comprehensive genetic analysis of the cystic fibrosis transmembrane conductance regulator from dried blood specimens-implications for newborn screening. Genet Med 8:557-562.
46. Kawchak DA, Schall JI, Zemel BS, Ohene-Frempong K, Stallings VA. 2007. Adequacy of dietary intake declines with age in children with sickle cell disease. J Am Diet Assoc 107:843-848.
47. Kelly A, Schall JI, Stallings VA, Zemel BS. 2008. Deficits in bone mineral content in children and adolescents with cystic fibrosis are related to height deficits. J Clin Densitom 11:581-589.
48. Kennedy TS, Fung EB, Kawchak DA, Zemel BS, Ohene-Frempong K, Stallings VA. 2001. Red blood cell folate and serum vitamin B12 status in children with sickle cell disease. J Pediatr Heme/Onc 23:165-169.
49. Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, Buchwald M, Tsui LC. 1989. Identification of the cystic fibrosis gene: Genetic analysis. Science 245:1073-1080. (Pubitemid 19231815)
50. Komlos J, Breitfelder A. 2008. Differences in the physical growth of US-born black and white children and adolescents ages 2-19, born 1942-2002. Ann Hum Biol 35:11-21.
51. KooWW, Hammami M, Shypailo RJ, Ellis KJ. 2004. Bone and body composition measurements of small subjects: Discrepancies from software for fan-beam dual energy X-ray absorptiometry. J Am Coll Nutr 23:647-650.
52. Kramer M, Rooks Y,Washington L, HA P. 1980. Pre- and postnatal growth and development in sickle cell anemia. J Pediatr 96:857-860.
53. Lappe JM, Stegman M, Davies KM, Barber S, Recker RR. 2000. A prospective study of quantitative ultrasound in children and adolescents. J Clin Densitom 3:167-175.
54. Laska-Mierzejewska T, Olszewska E. 2007. Anthropological assessment of changes in living conditions of the rural population in Poland in the period 1967-2001. Ann Hum Biol 34:362-376.
55. Le Roith D, Bondy C, Yakar S, Liu JL, Butler A. 2001. The somatomedin hypothesis: 2001. Endocr Rev 22:53-74.
56. Leib ES, Lewiecki EM, Binkley N, Hamdy RC. 2004. Official positions of the International Society for Clinical Densitometry. J Clin Densitom 7:1-6.
57. Leonard MB, Zemel BS. 2002. Current concepts in pediatric bone disease. Pediatr Clin North Am 49:143-173.
58. Leonard MB, Zemel BS, Kawchak DA, Ohene-Frempong K, Stallings VA. 1998. Plasma zinc status, growth, and maturation in children with sickle cell disease. J Pediatr 132:467-471.
59. Leung SS, Cole TJ, Tse LY, Lau JT. 1998. Body mass index reference curves for Chinese children. Ann Hum Biol 25:169-174.
60. Littlewood JM, Wolfe SP, Conway SP. 2006. Diagnosis and treatment of intestinal malabsorption in cystic fibrosis. Pediatr Pulmonol 41:35-49.
61. Luke B, BrownMB, Hediger ML, Nugent C, Misiunas RB, Anderson E. 2004. Fetal phenotypes and neonatal and early childhood outcomes in twins. Am J Obstet Gynecol 191:1270-1276.
62. Magkos F, Manios Y, Babaroutsi E, Sidossis LS. 2005. Quantitative ultrasound calcaneus measurements: Normative data for the Greek population. Osteoporos Int 16:280-288.
63. Margulies L, Horlick M, Thornton JC, Wang J, Ioannidou E, Heymsfield SB. 2005. Reproducibility of pediatric whole body bone and body composition measures by dual-energy X-ray absorptiometry using the GE Lunar Prodigy. J Clin Densitom 8:298-304.
64. Mehanna AS. 2001. Sickle cell anemia and antisickling agents then and now. Curr Med Chem 8:79-88.
65. Mei-Zahav M, Durie P, Zielenski J, Solomon M, Tullis E, Tsui LC, Corey M. 2005. The prevalence and clinical characteristics of cystic fibrosis in South Asian Canadian immigrants. Arch Dis Child 90:675-679.
66. Michaelsen KF. 1994. Short-term measurements of linear growth using knemometry. J Pediatr Endocrinol 7: 147-154.
67. Micklesfield L, Levitt N, Dhansay M, Norris S, van der Merwe L, Lambert E. 2006. Maternal and early life influences on calcaneal ultrasound parameters and metacarpal morphometry in 7- to 9-year-old children. J Bone Miner Metab 24:235-242.
68. Morris N, Udry J. 1980. Validation of a self-administered instrument to assess stage of adolescent development. J Youth Adolesc 9:271-280.
69. Mullis PE. 2005. Genetic control of growth. Eur J Endocrinol 152:11-31.
70. Nagel RL, Fleming AF. 1992. Genetic epidemiology of the beta s gene. Baillieres Clin Haematol 5:331-365.
71. Nelson MC, Zemel BS, Kawchak DA, Barden EM, Frongillo EAJ, Coburn SP, Ohene-Frempong K, Stallings VA. 2002. Vitamin B6 status of children with sickle cell disease. J Pediatr Hematol Oncol 24:463-469.
72. Norgan NG. 1995. Changes in patterns of growth and nutritional anthropometry in two rural modernizing Papua New Guinea communities. Ann Hum Biol 22:491-513.
73. Ogden CL, Kuczmarski RJ, Flegal KM, Mei Z, Guo S, Wei R, Grummer-Strawn LM, Curtin LR, Roche AF, Johnson CL. 2002. Centers for Disease Control and Prevention 2000 growth charts for the United States: Improvements to the 1977 National Center for Health Statistics version. Pediatrics 109:45-60.
74. Panter-Brick C. 1997. Seasonal growth patterns in rural Nepali children. Ann Hum Biol 24:1-18.
75. Pietrobelli A, Malavolti M, Fuiano N, Faith MS. 2007. The invisible fat. Acta Paediatr Suppl 96:35-38.
76. Platt OS, RosenstockW, Espeland MA. 1984. Influence of sickle hemoglobinopathies on growth and development. N Engl J Med 311:7-12.
77. Rona RJ, Chinn S. 1986. National Study of Health and Growth: Social and biological factors associated with height of children from ethnic groups living in England. Ann Hum Biol 13:453-471.
78. Rosenbloom AL. 2008. Insulin-like growth factor-I (rhIGF-I) therapy of short stature. J Pediatr Endocrinol Metab 21:301-315.
79. Rovner AJ, Stallings VA, Kawchak DA, Schall JI, Ohene-Frempong K, Zemel BS. 2008. High risk of vitamin D deficiency in children with sickle cell disease. J Am Diet Assoc 108:1512-1516.
80. Salomon LJ, Duyme M, Crequat J, Brodaty G, Talmant C, Fries N, Althuser M. 2006. French fetal biometry: Reference equations and comparison with other charts. Ultrasound Obstet Gynecol 28:193-198.
81. Sarnaik S, Soorya D, Kim J, Ravindranath Y, Lusher J. 1979. Periodic transfusions for sickle cell anemia and CNS infarction. Am J Dis Child 133:1254-1257.
82. Sarnaik SA, Lusher JM. 1982. Neurological complications of sickle cell anemia. Am J Pediatr Hematol Oncol 4:386-394.
83. Schall JI, Semeao EJ, Stallings VA, Zemel BS. 2002. Self-assessment of sexual maturity status in children with Crohn's disease. J Pediatr 141:223-229.
84. Schall JI, Zemel BS, Kawchak DA, Ohene-Frempong K, Stallings VA. 2004. Vitamin A status, hospitalizations, and other outcomes in young children with sickle cell disease. J Pediatr 145:99-106.
85. Serjeant GR. 1989. Geography and the clinical picture of sickle cell disease. An overview. Ann N Y Acad Sci 565:109-119.
86. Serjeant GR, Serjeant BE. 2001. Sickle cell anemia. Oxford: Oxford University Press.
87. Shoff SM, Ahn HY, Davis L, Lai H. 2006. Temporal associations among energy intake, plasma linoleic acid, and growth improvement in response to treatment initiation after diagnosis of cystic fibrosis. Pediatrics 117:391-400.
88. Stallings VA, Stark LJ, Robinson KA, Feranchak AP, Quinton H. 2008. Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: Results of a systematic review. J Am Diet Assoc 108:832-839.
89. Stein AD, Barnhart HX, Hickey M, Ramakrishnan U, Schroeder DG, Martorell R. 2003. Prospective study of protein-energy supplementation early in life and of growth in the subsequent generation in Guatemala. Am J Clin Nutr 78:162-167.
90. Stettler N, Zemel BS, Kawchak DA, Ohene-Frempong K, Stallings VA. 2001. Iron status of children with sickle cell disease. JPEN J Parenter Enteral Nutr 25:36-38. (Pubitemid 32057757)
91. Sun SS, Schubert CM, Chumlea WC, Roche AF, Kulin HE, Lee PA, Himes JH, Ryan AS. 2002. National estimates of the timing of sexual maturation and racial differences among US children. Pediatrics 110:911-919.
92. Tanner J. 1962. Growth at adolescence, with a general consideration of the effects of hereditary and environmental factors upon growth and maturation from birth to maturity. Oxford: Blackwell Scientific Publications.
93. Tanner JM HH, Goldstein H, Cameron N. 2001. assessment of skeletal maturity and prediction of adult height (TW3) method. London: W.B. Saunders.
94. Van Loan MD, Koehler LS. 1990. Use of total-body electrical conductivity for the assessment of body composition in middle-aged and elderly individuals. Am J Clin Nutr 51:548-552.
95. Verburg BO, Steegers EA, De Ridder M, Snijders RJ, Smith E, Hofman A, Moll HA, Jaddoe VW, Witteman JC. 2008. New charts for ultrasound dating of pregnancy and assessment of fetal growth: Longitudinal data from a population-based cohort study. Ultrasound Obstet Gynecol 31:388-396.
96. Wang WC, Helms RW, Lynn HS, Redding-Lallinger R, Gee BE, Ohene-Frempong K, Smith-Whitley K,Waclawiw MA, Vichinsky EP, Styles LA, Ware RE, Kinney TR. 2002. Effect of hydroxyurea on growth in children with sickle cell anemia: Results of the HUG-KIDS Study. J Pediatr 140:225-229.
97. Wells JC, Fuller NJ, Wright A, Fewtrell MS, Cole TJ. 2003. Evaluation of air-displacement plethysmography in children aged 5-7 years using a three-component model of body composition. Br J Nutr 90:699-707.
98. Wells JC, Williams JE, Fewtrell M, Singhal A, Lucas A, Cole TJ. 2007. A simplified approach to analysing bioelectrical impedance data in epidemiological surveys. Int J Obes (Lond) 31:507-514.
99. Whitten CF. 1961. Growth status of children with sickle cell anemia. Am J Dis Child 102:355-364.
100. Wilson JM. 1993. Cystic fibrosis. Vehicles for gene therapy. Nature 365:691-692.
101. Wosje KS, Knipstein BL, Kalkwarf HJ. 2006. Measurement error of DXA: Interpretation of fat and lean mass changes in obese and non-obese children. J Clin Densitom 9:335-340.
102. Yanni E, Grosse SD, Yang Q, Olney RS. 2009. Trends in pediatric sickle cell disease-related mortality in the United States, 1983-2002. J Pediatr 154:541-545.
103. Zemel BS, Kawchak DA, Fung EB, Ohene-Frempong K, Stallings VA. 2002. Effect of zinc supplementation on growth and body composition in children with sickle cell disease. Am J Clin Nutr 75:300-307.
104. Zemel BS, Kawchak DA, Ohene-Frempong K, Schall JI, Stallings VA. 2007. Effects of delayed pubertal development, nutritional status, and disease severity on longitudinal patterns of growth failure in children with sickle cell disease. Pediatr Res 61:607-613.
105. Zucchini S. 2008. Growth hormone use in the treatment of idiopathic short stature. Curr Opin Investig Drugs 9:396-401.